<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Local anesthetic agents dosing for epidural anesthesia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Local anesthetic agents dosing for epidural anesthesia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Local anesthetic agents dosing for epidural anesthesia</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Local anesthetic</td> <td class="subtitle1">Dose (mg)</td> <td class="subtitle1">Peak cephalad block height</td> <td class="subtitle1">Time to two-segment regression<br/> (1 SD or range) (minutes)*</td> <td class="subtitle1">Recommended time interval for top-up dose (minutes)<sup>¶</sup></td> </tr> <tr> <td>Chloroprocaine 2 to 3% plus<br/> 1:200,000 epinephrine<sup>[1,2]</sup></td> <td class="centered">600</td> <td class="centered">T5</td> <td class="centered">80 (15)</td> <td class="centered">45</td> </tr> <tr> <td>Lidocaine 1.5 to 2% plus<br/> 1:200,000 epinephrine<sup>[2,3]</sup></td> <td class="centered">300 to 400</td> <td class="centered">T4</td> <td class="centered">100 (50 to 60)</td> <td class="centered">60</td> </tr> <tr> <td>Bupivacaine 0.5 to 0.75% (plain)<sup>[4,5]</sup></td> <td class="centered">100 to 150</td> <td class="centered">T5</td> <td class="centered">150 to 190 (60 to 80)</td> <td class="centered">120</td> </tr> <tr> <td>Ropivacaine 1% (plain)<sup>[6]</sup><br/> Age 30 (18 to 40)<sup>Δ</sup></td> <td class="centered">150</td> <td class="centered">T8<sup>◊</sup></td> <td class="centered">143 (45 to 298)</td> <td class="centered">120</td> </tr> <tr> <td>Ropivacaine 1% (plain)<sup>[6]</sup><br/> Age 51 (41 to 59)<sup>Δ</sup></td> <td class="centered">150</td> <td class="centered">T6</td> <td class="centered">190 (100 to 340)</td> <td class="centered">120</td> </tr> <tr> <td>Ropivacaine 1% (plain)<sup>[6]</sup><br/> Age 71 (61 to 82)<sup>Δ</sup></td> <td class="centered">150</td> <td class="centered">T4<sup>◊</sup></td> <td class="centered">203 (105 to 378)</td> <td class="centered">120</td> </tr> <tr> <td>Levobupivacaine 0.75% (plain)<sup>[7]</sup><br/> Age 32 (18 to 44)<sup>Δ</sup></td> <td class="centered">125</td> <td class="centered">T8<sup>◊</sup></td> <td class="centered">166 (51)</td> <td class="centered">120</td> </tr> <tr> <td>Levobupivacaine 0.75% (plain)<sup>[7]</sup><br/> Age 57 (47 to 69)<sup>Δ</sup></td> <td class="centered">125</td> <td class="centered">T5</td> <td class="centered">158 (59)</td> <td class="centered">120</td> </tr> <tr> <td>Levobupivacaine 0.75% (plain)<sup>[7]</sup><br/> Age 78 (72 to 85)<sup>Δ</sup></td> <td class="centered">125</td> <td class="centered">T5<sup>◊</sup></td> <td class="centered">174 (61)</td> <td class="centered">120</td> </tr> </tbody></table></div><div class="graphic_footnotes">* Mean (1 SD or range).<br/>¶ Dosing intervals are approximate guidelines. In awake and cooperative patients, clinical monitoring for signs and symptoms (increase in blood pressure and heart rate or objective evaluation of dermatomal level of block) of dermatomal regression will indicate the need for a top-up dose.<br/>Δ Ages expressed as mean (range).<br/><font class="lozenge">◊</font> Note for ropivacaine and levobupivacaine the significant difference in peak block height between the youngest and oldest age groups.</div><div class="graphic_reference">References: 

<ol>
<li>Liu SS, Ware PD, Rajendran S. Effects of concentration and volume of 2-chloroprocaine on epidural anesthesia in volunteers. Anesthesiology 1997; 86:1288.</li>
<li>Kopacz DJ, Mulroy MF. Chloroprocaine and lidocaine decrease hospital stay and admission rate after outpatient epidural anesthesia. Reg Anesth 1990; 15:19.</li>
<li>Terai T, Yukioka H, Fujimori M. A double-blind comparison of lidocaine and mepivacaine during epidural anesthesia. Acta Anaesthesiol 1993; 37:607.</li>
<li>Kopacz DJ, Allen HW, Thompson GT. A comparison of epidural levobupivacaine 0.75% with racemic bupivacaine for lower abdominal surgery. Anesth analg 2000; 90:642.</li>
<li>Veering BT, Burm AGL, Van Kleef JW, et al. Epidural anesthesia with bupivacaine: Effects of age on neural blockage and pharmacokinetics. Anesth analg 1987; 66:589.</li>
<li>Simon MJG, Veering BT, Stienstra R, et al. The effects of age on neural blockade and hemodynamic changes after epidural anesthesia with ropivacaine. Anesth analg 2002; 94:1325.</li>
<li>Simon MJG, Veering BT, Stienstra R, et al. Effect of age on the clinical profile and systemic absorption and disposition of levobupivacaine after epidural administration. Br J Anaesth 2004; 93:512.</li></ol>Adapted with permission from: Salinas FV. Pharmacology of drugs used for spinal and epidural anesthesia and analgesia. In: Spinal and epidural anesthesia, Wong C (Ed), McGraw-Hill Education 2007. Copyright © 2017 McGraw-Hill Education. McGraw-Hill Education makes no representations or warranties as to the accuracy of any information contained in the McGraw-Hill Education Material, including any warranties of merchantability or fitness for a particular purpose. In no event shall McGraw-Hill Education have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with the McGraw-Hill Education Material, even if McGraw-Hill Education has been advised of the possibility of such damages.</div><div id="graphicVersion">Graphic 113031 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
